OCT 17, 2016 7:40 PM PDT

Gene Therapy to Prevent Heart Failure

WRITTEN BY: Kara Marker
For reasons not completely understood by scientists, our own heart muscle cells, called cardiomyocytes, secrete a protein that ultimately leads to heart failure. In a new study from Kumamoto University, researchers find out why and how to stop it.
Angiopoietin-like protein 2 (ANGPTL2) reduces the contractile force of the heart by both decreasing the production of cellular energy and the ability of calcium concentration to be regulated within the cardiomyocytes. Excessive secretion of these proteins occurs when aged cells and/or cells under stress due to high blood pressure, the researchers found in the recent Nature Communications study, which investigated the potential of developing gene therapy to treat ANGPTL-2-related heart failure.

"We genetically engineered a non-pathogenic virus which was designed to infect cardiac muscle cells and reproduce a special RNA molecule that inhibit the production of the ANGPTL2 protein," said Kumamoto University Professor Yuichi Oike. “Among knockout mice that could not produce [ANGPTL2], the development of heart failure was suppressed in a manner similar to moderate exercise.”

Oike’s study suggests gene therapy to inhibit production of ANGPTL2, which could provide beneficial therapeutic effects for people at risk of heart failure. Oike showed that these beneficial effects are possible in both a heart failure mouse model and in human cardiomyocytes differentiated from induced pluripotent stem cells (iPSCs), due to a correction in calcium concentration regulation and energy production when ANGPLT2 production was suppressed.

Excessive secretion of ANGPTL2 by cells experiencing stress causes chronic inflammation, which leads to heart failure but also other lifestyle-related diseases like atherosclerosis, obesity, diabetes, and cancer. The protein causes the development of these diseases because of its debilitating effect on the contractile force of the heart, but the good news is that moderate exercise can reduce its excessive production by cardiomyocytes, which is one of the reasons regular physical activity is famous for maintaining a healthy heart.

Individuals with severe heart failure are only 50 to 60 percent likely to survive five years, so an effective gene therapy could give thousands of Americans with heart failure a much better prognosis. 
 


Sources: Kumamoto University, American Heart Association
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 07, 2020
Cardiology
Investigating New Ways to Diagnose a Heart of Bone
JUL 07, 2020
Investigating New Ways to Diagnose a Heart of Bone
Calcific aortic stenosis, or calcific aortic valve disease (CAVD), is a progressive cardiovascular disease where the aor ...
SEP 05, 2020
Cardiology
Psoriasis and Hyperlipidemia May Put You at Risk for Chronic Kidney Disease
SEP 05, 2020
Psoriasis and Hyperlipidemia May Put You at Risk for Chronic Kidney Disease
The sad truth is that many diseases not only carry their own symptoms but can also increase the risk of the onset of ano ...
SEP 15, 2020
Cardiology
Dopamine Could Cause Heart Arrhythmia After Heart Failure
SEP 15, 2020
Dopamine Could Cause Heart Arrhythmia After Heart Failure
Everyone knows that friend with a tattoo of a molecule of dopamine. Usually associated with the pleasure response, it is ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
NOV 05, 2020
Cardiology
Investigating Platelet-Derived Extracellular Vesicles in Blood Clotting
NOV 05, 2020
Investigating Platelet-Derived Extracellular Vesicles in Blood Clotting
In our bodies, there are millions of signals and packages being sent and received every second. In the past several deca ...
NOV 20, 2020
Neuroscience
The Link Between Sleep Apnea and Autoimmune Disease
NOV 20, 2020
The Link Between Sleep Apnea and Autoimmune Disease
Researchers from the University of Georgia have found more evidence for the link between obstructive sleep apnea (OSA) a ...
Loading Comments...